Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
He Ting graduated from the Department of Biology in Tsinghua University with a Ph.D. degree, with his research interest in cancer immunology and metastasis during his graduate study. In 2015, Ting established ImmunoChina Pharmaceuticals Co. Ltd. and has worked as the CEO since then. ImmunoChina has received several rounds of investment by venture capitals such as Peter Thiel and Legend Capital, and now it is the leading bio-company focusing on innovative CAR-T therapy in China.